India Faces Metabolic Crisis Amidst Ozempic Approval and Access Debates

Imagine many people in India have sugar problems (diabetes) and are overweight, which can lead to heart and kidney issues.

A new medicine called Ozempic, which is an injection, has been approved.

It helps control sugar and lose weight.

However, it costs a lot of money, making it hard for most people to afford.

Some people think the government should control the price to make it cheaper, like other medicines.

Others believe that companies need to make profits to invent new medicines and that competition with generic versions after the patent expires will lower prices naturally.

There are also concerns that rich people might use it for looks while poor people can't even afford basic insulin.

Doctors warn about side effects, and some worry about people losing muscle instead of fat.

The debate is about how to make sure life-saving medicines are available to everyone, whether through government rules or by letting the market work.

The goal is to help people get healthier without making the gap between rich and poor even wider.